Randomized Study Comparing the Efficacy and Safety of Varenicline Tartrate to Placebo in Smoking Cessation When Subjects Are Allowed to Set Their Own Quit Date

• Status: Completed
• Trial end date: 2009-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The hypothesis is that varenicline will be effective (compared with placebo) for smoking cessation when subjects are allowed to set their own quit date within the first 5 weeks of treatment.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Varenicline

Criteria

Inclusion Criteria:

• Men and women

• 18 to 75 yrs old

• Motivated to stop smoking

• Smoke at least 10 cigarettes/day

Exclusion Criteria:

• Active psychiatric disease

• Severe or unstable cardiovascular or pulmonary disease

• Current or recent treatment to stop smoking

• Previous use of varenicline